Twenty Years of Vasoplegic Syndrome Treatment in Heart Surgery. Methylene Blue Revised
This study was conducted to reassess the concepts established over the past 20 years, in particular in the last 5 years, about the use of methylene blue in the treatment of vasoplegic syndrome in cardiac surgery.